These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19943157)

  • 21. Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes.
    Nishida Y; Takahashi Y; Nakayama T; Asai S
    Cardiovasc Diabetol; 2012 May; 11():53. PubMed ID: 22594344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration and Degree of Weight Gain and Incident Diabetes in Younger Versus Middle-Aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study.
    Wei GS; Coady SA; Reis JP; Carnethon MR; Coresh J; D'Agostino RB; Goff DC; Jacobs DR; Selvin E; Fox CS
    Diabetes Care; 2015 Nov; 38(11):2042-9. PubMed ID: 26358286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
    Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
    Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.
    Becker ML; Aarnoudse AJ; Newton-Cheh C; Hofman A; Witteman JC; Uitterlinden AG; Visser LE; Stricker BH
    Pharmacogenet Genomics; 2008 Jul; 18(7):591-7. PubMed ID: 18551039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.
    Becker ML; Visser LE; Newton-Cheh C; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Br J Clin Pharmacol; 2009 Jan; 67(1):61-7. PubMed ID: 19076153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
    Chatterjee R; Yeh HC; Shafi T; Anderson C; Pankow JS; Miller ER; Levine D; Selvin E; Brancati FL
    Am J Clin Nutr; 2011 May; 93(5):1087-91. PubMed ID: 21367942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study.
    Wei GS; Coady SA; Goff DC; Brancati FL; Levy D; Selvin E; Vasan RS; Fox CS
    Diabetes Care; 2011 Apr; 34(4):873-9. PubMed ID: 21346180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Esen-Sehir D; Kopf J; Hägele S; Plichta MM; Reif A; Freudenberg F
    Pharmacopsychiatry; 2022 Sep; 55(5):266-273. PubMed ID: 35732169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.
    Andreasen CH; Mogensen MS; Borch-Johnsen K; Sandbaek A; Lauritzen T; Almind K; Hansen L; Jørgensen T; Pedersen O; Hansen T
    BMC Med Genet; 2008 Dec; 9():118. PubMed ID: 19111066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations.
    North KE; Franceschini N; Avery CL; Baird L; Graff M; Leppert M; Chung JH; Zhang J; Hanis C; Boerwinkle E; Volcik KA; Grove ML; Mosley TH; Gu C; Heiss G; Pankow JS; Couper DJ; Ballantyne CM; Linda Kao WH; Weder AB; Cooper RS; Ehret GB; O'Connor AA; Chakravarti A; Hunt SC
    Acta Diabetol; 2010 Dec; 47 Suppl 1(Suppl 1):199-207. PubMed ID: 19855918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.
    Duncan BB; Schmidt MI; Pankow JS; Ballantyne CM; Couper D; Vigo A; Hoogeveen R; Folsom AR; Heiss G;
    Diabetes; 2003 Jul; 52(7):1799-805. PubMed ID: 12829649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC Brain MRI Study.
    Mayeda ER; Haan MN; Neuhaus J; Yaffe K; Knopman DS; Sharrett AR; Griswold ME; Mosley TH
    Neuroepidemiology; 2014; 43(3-4):220-7. PubMed ID: 25402639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
    Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
    Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic variant of NOS1AP effects on cardiac alternans of repolarization during exercise testing.
    Koskela J; Kähönen M; Nieminen T; Lehtinen R; Viik J; Nikus K; Niemelä K; Kööbi T; Tobin MD; Samani NJ; Turjanmaa V; Pörsti I; Lehtimäki T
    Scand J Clin Lab Invest; 2012 Apr; 72(2):100-7. PubMed ID: 22133205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin and incident type 2 diabetes: risk or protection?
    Schmidt MI; Duncan BB; Vigo A; Pankow JS; Couper D; Ballantyne CM; Hoogeveen RC; Heiss G;
    Diabetologia; 2006 Sep; 49(9):2086-96. PubMed ID: 16850292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary fiber intake and glycemic index and incidence of diabetes in African-American and white adults: the ARIC study.
    Stevens J; Ahn K; Juhaeri ; Houston D; Steffan L; Couper D
    Diabetes Care; 2002 Oct; 25(10):1715-21. PubMed ID: 12351467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study.
    Bi M; Kao WH; Boerwinkle E; Hoogeveen RC; Rasmussen-Torvik LJ; Astor BC; North KE; Coresh J; Köttgen A
    PLoS One; 2010 Jul; 5(7):e11690. PubMed ID: 20661421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study.
    Tin A; Köttgen A; Folsom AR; Maruthur NM; Tajuddin SM; Nalls MA; Evans MK; Zonderman AB; Friedrich CA; Boerwinkle E; Coresh J; Kao WH
    BMC Genet; 2015 May; 16():56. PubMed ID: 26058915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort.
    Wing MR; Ziegler JM; Langefeld CD; Roh BH; Palmer ND; Mayer-Davis EJ; Rewers MJ; Haffner SM; Wagenknecht LE; Bowden DW
    Int J Obes (Lond); 2011 Sep; 35(9):1173-82. PubMed ID: 21102551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating Common NOS1AP Variants in Patients with Implantable Cardioverter Defibrillators for Secondary Prevention : Evaluating SNPs in NOS1AP.
    Zang X; Zhang S; Li S; Wang X; Song W; Chen K; Ma J; Tu X; Xia Y; Zhao Y; Gao C
    J Interv Card Electrophysiol; 2022 Sep; 64(3):793-800. PubMed ID: 35353321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.